unknown
Stage
1
Investors
About
CureMatch provides an AI-driven clinical decision support platform for oncology that analyzes patients' genomic and clinical data to generate and rank personalized cancer treatment options, including combination therapies, for use by oncologists and healthcare providers.
Explore CureMatch's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.